Cancer worry linked to continued symptom burden

This article originally appeared here.
Share this content:
Cancer Worry Linked to Continued Symptom Burden
Cancer Worry Linked to Continued Symptom Burden

FRIDAY, April 27 (HealthDay News) -- Age, fatigue, symptom burden, and risk perception are significantly associated with greater cancer worry three years after completing adjuvant treatment for breast cancer, according to a study published online March 15 in Psycho-Oncology.

Kristin M. Phillips, Ph.D., from the Moffitt Cancer Center in Tampa, Fla., and colleagues analyzed responses from 202 stage 0 to II breast cancer patients regarding risk perception and cancer worry using the modified Lerman's Cancer Worry Scale. Symptom burden was assessed using the Memorial Symptom Assessment Scale, and fatigue severity was assessed using the Fatigue Symptom Inventory. All questionnaires were completed three years following adjuvant treatment.

The researchers found that age, fatigue, symptom burden, and risk perception each explained a significant proportion of cancer worry in patients. When taken together, fatigue, symptom burden, and risk perception accounted for a significant portion (27 percent) of the variance in cancer worry, when controlling for demographic and clinical factors.

"The hypothesis was supported that fatigue, symptom burden, and risk perception are associated with cancer worry among breast cancer survivors," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs